Teva Launches New Generic Focalin XR Strength

Teva announced the availability of a new 5mg strength of Dexmethylphenidate HCl Extended-Release (ER) Capsules, the generic version of NovartisFocalin XR Extended-Release Capsules.

Dexmethylphenidate HCl is a Schedule II narcotic that is indicated for use in attention deficit hyperactivity disorder (ADHD). Dexmethylphenidate, a central nervous system (CNS) stimulant, is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.

RELATED: Teva Launches Generic Baraclude Tablets

The new 5mg strength capsules are available in 100-count bottles. Dexmethylphenidate HCl ER Capsules are already available in 15mg, 30mg, and 40mg strengths.

For more information call (888) 838-2872 or visit